ANI Pharmaceuticals, Inc. announced an agreement to acquire Egetis Therapeutics, according to source material published on November 5, 2026. The reported purchase consideration is $560,000,000. This summary is limited to the approved transaction facts in the cited source evidence.
ANI Pharmaceuticals, Inc. announced an agreement to acquire Egetis Therapeutics
ANI Pharmaceuticals, Inc. announced an agreement to acquire Egetis Therapeutics
AcquisitionUSD560,000,000ManufacturingSE
Get the full Egetis Therapeutics company profile
Access contacts, investors, buying signals & more
Acquired
Egetis Therapeutics
SwedenManufacturing
Deal value
USD560,000,000
November 5, 2026
Acquirer
ANI Pharmaceuticals, Inc.
Pharmaceutical Manufacturing
Unlock GTM signals
Discover Egetis Therapeutics's tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at Egetis Therapeutics.